Summary
- Current Price
- As of today, LBRX price is $28.30, up +0.64% in the most recent trading session on
- Current Price All-Time High
- LBRX price is currently -15.45% below its historical high of $33.47 set on
- Market Cap
- LBRX current market cap is $812M, with unknown 1-year change
- PE Ratio
- LBRX PE ratio is unknown
- Revenue
- LBRX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for LBRX is on
Profile
| Metric | Value |
|---|---|
| Full Name | LB Pharmaceuticals Inc |
| Ticker | NASDAQ: LBRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | lbpharma.us |
| Employees | 27 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $28.30 | |
| Price, 1D Change | +0.64% | |
| $812M | ||
| - | ||
| - | ||
| 0.76 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.00 | ||
| EPS, 1Y Change | +64.57% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.00 | ||
| EPS Estimate | N/A | -$3.50 |
| EPS Est. Change | N/A | -251.50% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $28.30 | |
| Price Target | - | $38.50 |
| Price Tgt. Change | - | +36.04% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.72 | -$1.00 | +78.91% | |
| -$3.50 | N/A | -251.50% | |
| -$4.49 | N/A | -350.87% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $28.30 | |
| $21.80 | ||
| SMA 200 vs Price | -22.96% | |
| $28.11 | ||
| SMA 50 vs Price | -0.68% | |
| 0.76 | ||
| $1.72 | ||
| 43.25 | ||
| 57.78% | ||
| 66.13% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.00 | ||
| -$321.00K | ||
| - | ||
| -$30.40M | ||
| - | ||
| -$25.21M | ||
| - | ||
| -$30.08M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 41.44 | ||
| 41.44 | ||
| - | ||
| - | ||
| 42.14 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.14 | ||
| -9.82 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $301.31M | ||
| $295.21M | ||
| $312.93M | ||
| $308.43M | ||
| $11.62M | ||
| $7.44M | ||
| $3.57M | ||
| $730.00K | ||
| $2.13M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $25.21M | ||
| $30.08M | ||
| $321.00K | ||
| $0.00 | ||
| $321.00K | ||
| $0.00 | ||
| $1,000.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$35.21M | ||
| -$39.89M | ||
| $302.56M | ||
| $52.00K | ||
| -$35.26M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | ||
| Craig-Hallum | ||
| Stifel | → | |
| Stifel | → | |
| Stifel | ||
| Piper Sandler | ||
| Leerink Partners |
Analyst sentiment
Institutional ownership
Screeners with LBRX
FAQ
What is the ticker symbol for LB Pharmaceuticals Inc?
The ticker symbol for LB Pharmaceuticals Inc is NASDAQ:LBRX
Does LB Pharmaceuticals Inc pay dividends?
No, LB Pharmaceuticals Inc does not pay dividends
What sector is LB Pharmaceuticals Inc in?
LB Pharmaceuticals Inc is in the Healthcare sector
What industry is LB Pharmaceuticals Inc in?
LB Pharmaceuticals Inc is in the Biotechnology industry
What country is LB Pharmaceuticals Inc based in?
LB Pharmaceuticals Inc is headquartered in United States
When did LB Pharmaceuticals Inc go public?
LB Pharmaceuticals Inc initial public offering (IPO) was on September 11, 2025
Is LB Pharmaceuticals Inc in the S&P 500?
No, LB Pharmaceuticals Inc is not included in the S&P 500 index
Is LB Pharmaceuticals Inc in the NASDAQ 100?
No, LB Pharmaceuticals Inc is not included in the NASDAQ 100 index
Is LB Pharmaceuticals Inc in the Dow Jones?
No, LB Pharmaceuticals Inc is not included in the Dow Jones index
When was LB Pharmaceuticals Inc last earnings report?
LB Pharmaceuticals Inc's most recent earnings report was on May 12, 2026
When does LB Pharmaceuticals Inc report earnings?
The next expected earnings date for LB Pharmaceuticals Inc is August 31, 2026
Data Sources & References
- LBRX Official Website lbpharma.us
- LBRX Profile on Yahoo Finance finance.yahoo.com/quote/LBRX
- LBRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lbrx